Ewha Womans University Medical Center
Pulmonary hypertension treatment cost in the Republic of Korea runs from $100 to $200 for a consultation with a pulmonologist and includes diagnostics like lab tests ranging from $100 to $300. Total expenses depend on drug therapy protocols, disease severity, and the need for surgical interventions. Patients typically save 40-60% compared to the US. Top cities for this treatment include Seoul and Incheon.
Typical Pulmonary Hypertension Treatment Costs in Republic of Korea
Bookimed Expert Insight: For complex cases, multidisciplinary centers like Asan Medical Center are best. They perform 45% of South Korea's heart transplants with a 90% success rate. Patients needing lung transplants should consider Gangnam Severance Hospital, the first in Korea to perform this procedure. For international leadership in care, Dr. Kyung Hee Kim at SEJONG Hospital develops global clinical guidelines for pulmonary hypertension. JCI-accredited facilities in Seoul offer high volumes, seeing over 10,000 patients daily, ensuring significant expertise in rare vascular conditions.
| Republic of Korea | Turkey | Austria | |
| Pulmonary hypertension stem cell treatment | - | from $12,000 | from $55,000 |
| LDL Apheresis | - | from $1,650 | - |
No hidden fees – just official clinic prices. Pay at the clinic for Pulmonary hypertension treatment and use a flexible installment plan if needed.
Bookimed is committed to your safety. We only work with medical institutions that maintain high international standards in Pulmonary hypertension treatment and have the necessary licenses to serve international patients worldwide.
Bookimed offers free expert assistance. A personal medical coordinator supports you before, during, and after your treatment, solving any issues. You're never alone on your Pulmonary hypertension treatment journey.
Dr. Oh Dong Joo is a cardiologist. He specializes in coronary artery disease, valvular heart disease, heart failure, hypertension, and atrial fibrillation.
MD and PhD, Korea University. Professor of Cardiology, Korea University. Cardiology Fellow, Emory University. Clinical Instructor, Cornell University.
Leadership: Chairman, Korean Society of Cardiology. President, Korean Society of Interventional Cardiology. President, Korean Chapter of the ACC. Director, Cardiovascular Research Institute, Korea University.
Publications: 386 total. 242 SCI-indexed international papers.
Dr. Kyung-Hee Kim, MD, PhD, is Director of the Heart Transplantation Center and Head of Cardiology at Incheon Sejong Hospital. She earned her MD, MS, and PhD at Seoul National University College of Medicine. She completed international fellowships, including research at the Mayo Clinic.
Her expertise includes advanced heart failure, transplant evaluation and management, mechanical circulatory support (VAD, ECMO), pulmonary hypertension, complex cardiomyopathies, and genetic, valvular, and adult congenital heart disease.
She leads multidisciplinary cardiac care. She develops clinical protocols and education programs and contributes to research and guideline development in pulmonary hypertension and heart failure. She serves on the AHA Clinical Cardiology Membership Committee.
Dr. Dong Hyeon Lee is a hematologist-oncologist at Ewha Womans University Medical Center in Seoul. He specializes in bone marrow transplantation, including alternate donor and mismatched transplants. Dr. Lee treats colon cancer, myeloma, and lymphoma. He is a member of multiple professional oncology societies.
Specialized pulmonary hypertension (PH) programs in South Korea are primarily located within major tertiary university hospitals in Seoul. These centers, including Asan Medical Center and Severance Hospital, utilize multidisciplinary teams of cardiologists and pulmonologists. They provide advanced diagnostics like right-heart catheterization and specialized pulmonary vascular therapies.
Bookimed Expert Insight: While many search for a standalone pulmonary hypertension clinic, our data shows top Korean care is often found within large specialized departments. For instance, Dr. Kyung Hee Kim at Sejong Hospital leads heart transplantation and specializes specifically in pulmonary hypertension. Choosing a center with high heart or lung transplant volumes often ensures access to the most experienced vascular specialists.
Patient Consensus: Patients emphasize that seeking care at major Seoul university hospitals is vital for accessing specialized PH medications and precise right-heart catheterization. They note it is important to confirm the hospital has a dedicated pulmonary vascular specialist rather than just a general cardiology department.
Balloon Pulmonary Angioplasty (BPA) is available in South Korea at specialized cardiovascular centers. Major institutions like Severance Hospital and Asan Medical Center provide this interventional treatment for patients with chronic thromboembolic pulmonary hypertension (CTEPH). These centers use multidisciplinary teams to manage inoperable or residual cases.
Bookimed Expert Insight: While BPA is widely discussed, top-tier Korean centers like Asan Medical Center prioritize high-volume surgical expertise. Asan performs 45% of South Korea’s heart transplants and maintains a 90% success rate for organ procedures. This volume-to-outcome correlation suggests that patients should prioritize centers handling the highest daily inpatient loads, such as Severance with 1.6 million annual outpatients.
Patient Consensus: Patients emphasize finding specialized CTEPH centers because general clinics may not offer BPA or pulmonary endarterectomy. They also note that a formal workup at a high-volume facility can often change a patient's eligibility from inoperable to surgical candidates.
Top South Korean hospitals assign dedicated multidisciplinary teams to pulmonary hypertension patients. These centers typically coordinate care through pulmonologists and cardiologists. Facilities like Asan Medical Center and Seoul National University Hospital employ comprehensive teams to manage complex cases and advanced treatment protocols.
Bookimed Expert Insight: Clinical data shows a high concentration of expertise in Seoul, where hospitals like Asan Medical Center handle 45% of the nation's heart transplants. For patients, this means choosing a major Seoul center ensures a team with higher procedural volume. These teams are more likely to have established protocols for managing right-heart strain and specialized infusions compared to smaller regional clinics.
Patient Consensus: Patients note that care in large Korean hospitals is highly structured around a main specialist. They emphasize the importance of asking for a dedicated nurse coordinator to help manage complex testing and medication schedules between visits.
Patients should expect a multi-disciplinary evaluation involving JCI-accredited facilities in Seoul. Specialists use echocardiograms and right heart catheterization to confirm the diagnosis. The process identifies the specific cause of breathlessness among 5 clinical groups. Most diagnostic pathways conclude within 1 week at major Korean centers.
Bookimed Expert Insight: While many hospitals offer basic cardiology, Asan Medical Center performs 45% of heart transplants in South Korea. This volume suggests deep expertise in complex cases like advanced pulmonary hypertension. Choosing a center with high transplant volumes often ensures access to more experienced surgical teams for chronic clot removal.
Patient Consensus: Patients note the evaluation is a broad sorting process to find the specific cause of fatigue and swelling. They emphasize that while basic tests might look normal, specialists often continue investigating if symptoms persist during walking.
South Korea offers most modern pulmonary hypertension therapies, including recently approved agents like Winrevair and Opsynvi. While oral and inhaled options are widely available, intravenous epoprostenol remains a significant gap. Patients typically access advanced regimens at JCI-accredited academic centers in Seoul.
Bookimed Expert Insight: While drug availability is high, patients should focus on centers like Asan Medical Center. It handles over 65,000 operations yearly and performs 45% of Korea's heart transplants. This high volume often ensures faster access to the latest pharmaceutical protocols and multidisciplinary specialist teams.
Patient Consensus: Patients note that while medications are available in Seoul, insurance and reimbursement rules often dictate actual access. Bringing a detailed treatment history is essential for specialists to navigate these local prescription requirements.
Follow-up visits in South Korea occur 2 to 4 weeks after starting pulmonary hypertension therapy. Specialists at JCI-accredited centers in Seoul monitor drug tolerance and clinical response. These sessions include repeat echocardiography, bloodwork, and functional walk tests to ensure patient safety and dose accuracy.
Bookimed Expert Insight: South Korea's top cardiovascular centers, like Asan Medical Center, handle 45% of the country's heart transplants. This massive volume translates into highly standardized follow-up protocols. Patients benefit from the BESTcare digital system at centers like Seoul National University Bundang Hospital. This technology prevents medical errors during complex medication adjustments.
Patient Consensus: Patients note that initial visits are very data-heavy and require bringing a detailed symptom log. They emphasize that feeling better doesn't mean skipping tests, as objective results can change silently.